Inventor
ZHAO ZHONGDONG
US32 patents
⚠️ This page may combine multiple inventors who share the name “ZHAO ZHONGDONG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
GILEAD SCIENCES INC
16 patentsUS9504684B2Nov 29, 2016
Syk inhibitors
GILEAD SCIENCES INC18 citations92
US9290505B2Mar 22, 2016
Substituted imidazo[1,2-a]pyrazines as Syk inhibitors
GILEAD SCIENCES INC23 citations92
US11224600B2Jan 18, 2022
Compounds for inhibition of alpha 4 beta 7 integrin
GILEAD SCIENCES INC9 citations84
US10342794B2Jul 9, 2019
Substituted imidazo[1,2-a]pyrazines as Syk inhibitors
GILEAD SCIENCES INC5 citations84
US9968601B2May 15, 2018
Substituted imidazo[1,2-a]pyrazines as Syk inhibitors
GILEAD SCIENCES INC7 citations84
US9376441B2Jun 28, 2016
Substituted pyrrolidines as SYK inhibitors
GILEAD SCIENCES INC17 citations82
US10828299B2Nov 10, 2020
Crystalline monomesylate salt of 6-(6-aminopyrazin-2-yl)-n-(4-(4-(oxetan-3-yl)piperazin-1-yl)phenyl)imidazo[1,2-a]pyrazin-8-amine
GILEAD SCIENCES INC3 citations73
US10005774B2Jun 26, 2018
Syk inhibitors
GILEAD SCIENCES INC4 citations72
US9931338B2Apr 3, 2018
Syk inhibitors
GILEAD SCIENCES INC3 citations72
US11179383B2Nov 23, 2021
Compounds for inhibition of α4β7 integrin
GILEAD SCIENCES INC3 citations71
US11116760B2Sep 14, 2021
Quinoline derivatives
GILEAD SCIENCES INC3 citations71
US10040781B2Aug 7, 2018
Tank-binding kinase inhibitor compounds
GILEAD SCIENCES INC3 citations71
US12053462B2Aug 6, 2024
Quinoline derivatives
GILEAD SCIENCES INC0 citations61
US11174256B2Nov 16, 2021
Imidazopyridine derivatives
GILEAD SCIENCES INC2 citations61
US11578069B2Feb 14, 2023
Compounds for inhibition of α4 β7 integrin
GILEAD SCIENCES INC1 citations59
US10253019B2Apr 9, 2019
Tank-binding kinase inhibitor compounds
GILEAD SCIENCES INC0 citations51
GILEAD CONNECTICUT INC
6 patentsUS8748607B2Jun 10, 2014
Imidazopyrizine syk inhibitors
GILEAD CONNECTICUT INC34 citations97
US9796718B2Oct 24, 2017
6-(benzo[d]thiazol-5-yl)-n-(3,4-dimethoxyphenyl)imidazo[1,2-a]pyrazin-8-amine
GILEAD CONNECTICUT INC14 citations92
US10092583B2Oct 9, 2018
Imidazopyridines Syk inhibitors
GILEAD CONNECTICUT INC5 citations84
US9505785B2Nov 29, 2016
Pyridone and aza-pyridone compounds and methods of use
GILEAD CONNECTICUT INC3 citations71
US10344040B2Jul 9, 2019
Pyridone and aza-pyridone compounds and methods of use
GILEAD CONNECTICUT INC0 citations51
US10053469B2Aug 21, 2018
Pyridone and aza-pyridone compounds and methods of use
GILEAD CONNECTICUT INC0 citations51
BLOMGREN PETER A
3 patentsUS9562056B2Feb 7, 2017
Imidazopyridines Syk inhibitors
BLOMGREN PETER A11 citations83
US8426424B2Apr 23, 2013
Certain substituted amides, method of making, and method of use thereof
BLOMGREN PETER A5 citations72
US8247550B2Aug 21, 2012
Certain substituted amides, method of making, and method of use thereof
BLOMGREN PETER A1 citations51
KRONOS BIO INC
3 patentsUS11517570B2Dec 6, 2022
Crystalline succinate salt of 6-(6-aminopyrazin-2-yl)-n-(4-(4-(oxetan-3-yl)piperazin-1-yl)phenyl)imidazo[1,2-a]pyrazin-8-amine
KRONOS BIO INC1 citations72
US10842803B2Nov 24, 2020
Imidazopyridines Syk inhibitors
KRONOS BIO INC3 citations72
US12263163B2Apr 1, 2025
Crystalline succinate salt of 6-(6-aminopyrazin-2-yl)-n-(4-(4-(oxetan-3-yl)piperazin-1-yl)phenyl)imidazo[1,2-a]pyrazin-8-amine as a Syk inhibitor
KRONOS BIO INC0 citations62